Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Abattis Bioceuticals Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by bullrush18on Feb 01, 2018 11:23am
197 Views
Post# 27479675

RE:What about their extraction technology?

RE:What about their extraction technology?That's not anyone on this board's fault. They were reading the press releases from the company touting this.  And then Rob  Abenante refuses to a) address shareholders directly (has anyone had luck reaching him? What's his email address? Just a pr guy who doen's really know much). 

The onus on the RayBot technology's effeicacy should have been double tested by an independent lab and we all knew it.  It's fine for me to say, wow, look at my tech, it works, look at my numbers! but then refuse - at least this far- to have those numbers verified. 

And then so stupid raises. Great at . 40 and then again but then .60? And he can't get it filled. No wonder.  

Now I may be completely wrong and this guy might be the biggest fckin' genius to walk the planet in which case you will all be rich. Good luck!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities